�y��vlog

“Did we really learn?” said Marc Veldhoen, an immunologist at the University of Lisbon and Gulbenkian Institute for Molecular Medicine.

"Treating patients with epilepsy allows us to investigate the purpose of generating new neurons in our brains. We observe that one of reasons is to learn from the conversations we have" said co-corresponding author Michael Bonaguidi, an associate professor of stem cell biology and regenerative medicine, gerontology, biochemistry and molecular medicine, biomedical engineering, and neurological surgery, and assistant director of the USC Neurorestoration Center.

"Sleeper cells can be reawakened and cause estrogen receptor positive breast cancers to relapse years -- in some cases as long as a decade -- after patients were believed to be in remission," said study author Pradipta Ghosh, M.D., a professor in the Departments of Medicine and Cellular and Molecular Medicine at UC San Diego School of Medicine.

In a new review article in the journal, Endocrine Practice, Michael Holick, PhD, MD, professor of medicine, pharmacology, physiology & biophysics and molecular medicine at Boston University Chobanian & Avedisian School of Medicine, compares and contrasts the 2024 Endocrine Society's Clinical Guidelines on Vitamin D with those he helped design in 2011.

Researchers from Professor Vijay Tiwari's research group at the Department of Molecular Medicine, University of Southern Denmark, have developed a new method called MoPEDE, which has the potential to improve epilepsy treatment.